home / stock / tvtx / tvtx articles

TVTX Articles, Travere Therapeutics Inc Com - From 12/05/23

Stock Information
Company Name: Travere Therapeutics Inc Com
Stock Symbol: TVTX
Market: NASDAQ
Menu
TVTX TVTX Quote TVTX Short TVTX News TVTX Articles TVTX Message Board
Get TVTX Alerts

News, Short Squeeze, Breakout and More Instantly...
Why Daktronics Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session | Benzinga

Shares of Daktronics, Inc. (NASDAQ: DAKT) moved lower during Tuesday’s session following weak quarterly results. Daktronics posted quarterly ...
What's Going On With Travere Therapeutics Stock? | Benzinga

Travere Therapeutics, Inc. (NASDAQ: TVTX) shares are trading higher Tuesday. The company announced several FDA regulatory updates after the market ...

NIO Reports Q3 Results, Joins Hovnanian Enterprises, Signet Jewelers And Other Big Stocks Moving Higher On Tuesday | Benzinga

U.S. stocks traded mostly lower, with the Dow Jones index falling more than 100 points on Tuesday. Shares of NIO Inc. (NYSE: NIO) moved higher duri...

Travere Therapeutics to Report Third Quarter 2023 Financial Results | Benzinga

SAN DIEGO, Oct. 24, 2023 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ:TVTX) today announced it will report third quarter 2023 financia...
Travere Therapeutics to Present Abstracts at the American Society of Nephrology (ASN) Kidney Week 2023 | Benzinga

Two late-breaking high-impact oral presentations of the Phase 3 PROTECT Study of FILSPARI® (sparsentan) in IgAN and Phase 3 DUPLEX Study of s...

Travere Therapeutics to Present Abstracts at the 17th International Symposium on IgA Nephropathy (IIGANN 2023) | Benzinga

SAN DIEGO, Sept. 26, 2023 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ:TVTX) today announced that the Company and its collaborators wi...

Micron Technology To Rally Around 21%? Here Are 10 Other Analyst Forecasts For Friday | Benzinga

Loop Capital increased the price target for Splunk Inc. (NASDAQ: SPLK) from $135 to $157. Loop Capital analyst Yun Kim downgraded the stock from...
Back To Back Trial Failures: Analyst Weighs In On Travere Therapeutics' Prospects, Challenges | Benzinga

William Blair downgraded Travere Therapeutics Inc (NASDAQ: TVTX) to Market Perform. Thursday, the company's head-to-head Ph...

Dow Tumbles 200 Points; Darden Restaurants Posts Upbeat Profit | Benzinga

U.S. stocks traded lower toward the end of trading, with the Dow Jones falling around 200 points on Thursday. The Dow traded down 0.58% to 34,239.4...

Why Seelos Therapeutics Shares Are Trading Lower By 31%? Here Are Other Stocks Moving In Thursday's Mid-Day Session | Benzinga

Gainers MSP Recovery, Inc. (NASDAQ: LIFW) shares climbed 81.5% to $0.2793 after jumping 64% on Wednesday. Near Intelligence, Inc. (NASDAQ: NIR) g...
Previous 10 Next 10